Evidence map›Paper›PMID 41832772›Full record

ArticleAging cell2026

Regulation of Lipid Dysmetabolism and Neuroinflammation Progression Linked With Alzheimer's Disease Through Modulation of Dgat2.

Archana Yadav, Xiaosen Ouyang, Morgan Barkley, John C Watson, Kishore Madamanchi, Josh Kramer, Jianhua Zhang, Girish C Melkani

Abstract read
In one paragraph

Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Archana YadavDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Xiaosen OuyangDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Morgan BarkleyDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
John C WatsonDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kishore MadamanchiDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Josh KramerDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jianhua ZhangDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Girish C MelkaniDepartment of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0003-0353-4633

Funding

Optimized Circadian Rhythms for the Prevention of Alzheimer's DiseaseRF1AG068550 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MELKANI, GIRISH C., PANDA, SATCHIDANANDA · 2020 to 2020
$3.0M
Molecular basis of circadian rhythms disruptions linked cardiometabolic disorders and their mitigation using dietary interventionR01AG065992 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MELKANI, GIRISH C. · 2019 to 2023
$1.9M
Promoting circadian rhythms to optimize gut-to-brain signaling for Alzheimer's diseaseRF1NS133378 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MELKANI, GIRISH C. · 2023 to 2023
$1.9M
Optimized Circadian Rhythms for the Prevention of Alzheimer's DiseaseR01AG068550 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MELKANI, GIRISH C., PANDA, SATCHIDANANDA · 2024 to 2024
$736k
NIA NIH HHS R01 AG065992NIA NIH HHS R01 AG068550NIA NIH HHS RF1 AG068550NIH HHS AG065992NIH HHS AG072895NIH HHS AG081687NIH HHS RF1NS133378NINDS NIH HHS RF1 NS133378
6 · The paper itself

Abstract

Alzheimer's disease (AD), an age-associated neurodegenerative disorder, is characterized by progressive cognitive decline, amyloid-β (Aβ) accumulation (including soluble oligomers and deposited aggregates), lipid dysregulation, and neuroinflammation. Although mutations in the amyloid precursor protein (APP) and accumulation of Aβ42 are established drivers of pathology, the mechanisms connecting oligomeric amyloid toxicity with lipid metabolism and inflammatory responses remain poorly understood. Here, we employed complementary Drosophila and mouse models to dissect these relationships. Panneuronal, glial or mushroom body specific expression of humanized App

Indexed as

Alzheimer DiseaseDiacylglycerol O-AcyltransferaseLipid MetabolismNeuroinflammatory DiseasesAmyloid beta-PeptidesAnimalsDisease Models, AnimalDisease ProgressionDrosophilaHumansMiceAmyloid beta-PeptidesDiacylglycerol O-AcyltransferaseagingAlzheimer's diseaseamyloid‐β42diacylglycerol O‐acyltransferase 2Drosophila and mouse modelslipid metabolismneuroinflammationsleep‐circadian rhythms

Identifiers

PMID41832772
PMCPMC13093376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.